Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey
Key result
Post-LAAO anticoagulation strategies were highly heterogeneous across 33 European centres, with 41% prescribing no therapy after 6 months in patients without OAC contraindications.
Why the study?
What are the current indications and post-implantation anticoagulation strategies for left atrial appendage occluder (LAAO) in Europe?
Population
33 centres in 13 European countries performing left atrial appendage occluder implantation for stroke…
Design
Cross-sectional
Authors
Discussion
Loading...
Member takes
Implication
Heterogeneous post-LAAO anticoagulation persists across Europe; leaves open optimal strategy and warrants prospective trials.
Study Design
Type
Cross-Sectional (n=33)
Multicenter
Yes
Structured PICO
What are the current indications and post-implantation anticoagulation strategies for left atrial appendage occluder (LAAO) in Europe?
P
Population
A survey of 33 centres in 13 European countries assessing indications and anticoagulation strategies post-left atrial appendage occluder implantation for stroke prevention in non-valvular atrial fibrillation.
E
Exposure
Left atrial appendage occluder (LAAO) implantation and post-implantation anticoagulation strategies
O
Outcome
Indications for LAAO and post-implantation anticoagulation strategies
There is significant heterogeneity in post-LAAO anticoagulation strategies across European centers, highlighting a gap between clinical practice and randomized trial evidence.
Cite This Study
Tilz et al. (2017) conducted a cross-sectional in non-valvular atrial fibrillation (n=33). Post-LAAO anticoagulation strategies was evaluated on Indications and anticoagulation strategies post-LAAO implantation. Post-LAAO anticoagulation strategies were highly heterogeneous across 33 European centres, with 41% prescribing no therapy after 6 months in patients without OAC contraindications.